Abeona Therapeutics
ABEO
#7595
Rank
S$0.35 B
Marketcap
$8.21
Share price
-0.08%
Change (1 day)
34.21%
Change (1 year)

P/E ratio for Abeona Therapeutics (ABEO)

P/E ratio as of November 2024 (TTM): -2.03

According to Abeona Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.03093. At the end of 2022 the company had a P/E ratio of -0.4595.

P/E ratio history for Abeona Therapeutics from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.459514.76%
2021-0.4004-76.79%
2020-1.73-19.8%
2019-2.15-64.45%
2018-6.05-74.8%
2017-24.0216.9%
2016-7.5815.03%
2015-6.595648.72%
2014-0.1146-102.92%
20133.92-949.01%
2012-0.4615-92.95%
2011-6.5550.44%
2010-4.35114.24%
2009-2.03626.19%
2008-0.2797-11.11%
2007-0.3146-59.04%
2006-0.7680-84.34%
2005-4.91-4.94%
2004-5.16-47.61%
2003-9.85372.78%
2002-2.08-77.95%
2001-9.45

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
70.4-3,568.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
54.1-2,762.38%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.